Covered recipient · General Payments record
SAMUEL LEETMAA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$660.13
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $627.93 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $235.05 | 13 |
| Novo Nordisk AS | $179.06 | 9 |
| Lilly USA, LLC | $71.18 | 4 |
| Smith & Nephew, Inc. | $58.30 | 2 |
| Acerta Pharma LLC | $47.90 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.74 | 1 |
| Merck Sharp & Dohme Corporation | $15.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.64 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157728 | CMS |
| ABBVIE INC. | $24.46 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157730 | CMS |
| ABBVIE INC. | $20.91 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157732 | CMS |
| ABBVIE INC. | $31.20 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157734 | CMS |
| ABBVIE INC. | $16.62 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157736 | CMS |
| ABBVIE INC. | $17.30 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157738 | CMS |
| ABBVIE INC. | $12.85 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157740 | CMS |
| ABBVIE INC. | $24.42 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157742 | CMS |
| ABBVIE INC. | $19.49 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157744 | CMS |
| ABBVIE INC. | $19.44 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157746 | CMS |
| ABBVIE INC. | $18.09 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157748 | CMS |
| ABBVIE INC. | $9.89 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157750 | CMS |
| ABBVIE INC. | $14.74 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157752 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.41 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104730881 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.43 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104442883 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.06 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105698332 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.74 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118014878 | CMS |
| Lilly USA, LLC | $17.12 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135099756 | CMS |
| Lilly USA, LLC | $17.21 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135080230 | CMS |
| Lilly USA, LLC | $21.54 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135083152 | CMS |
| Lilly USA, LLC | $15.31 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135102577 | CMS |
| Merck Sharp & Dohme LLC | $15.70 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141919654 | CMS |
| Novo Nordisk Inc | $17.41 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097835367 | CMS |
| Novo Nordisk Inc | $17.73 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096607918 | CMS |
| Novo Nordisk Inc | $4.74 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097442499 | CMS |
| Novo Nordisk Inc | $22.38 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097512606 | CMS |
| Novo Nordisk Inc | $24.39 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096782305 | CMS |
| Novo Nordisk Inc | $20.63 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097490885 | CMS |
| Novo Nordisk Inc | $27.63 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097623109 | CMS |
| Novo Nordisk Inc | $25.33 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096873485 | CMS |
| Novo Nordisk Inc | $18.82 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097019844 | CMS |
| Smith+Nephew, Inc. | $28.95 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149601620 | CMS |
| Smith+Nephew, Inc. | $29.35 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149601622 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.